The Danish drugmaker said it had decided to terminate development of the first-in-class, oral glutamate mGluR4 positive allosteric modulator – which was Pexton’s only clinical-stage programme when it was bought in 2018 – after the drug missed all its objective in the phase 2 study..
Lundbeck drops Parkinson’s drug acquired ... - Cure Parkinson's
Lundbeck drops Parkinson’s drug acquired in €905m deal
Written by
Farooqji
To view profiles and participate in discussions please or .
Not what you're looking for?
You may also like...
Switch to cheaper drugs leaves Parkinson’s patients suffering ‘devastating effects’
cheaper form of the drug....
Travelling with Parkinson’s
It’s only relatively recently that I’ve discovered what a challenge it is travelling with...
PEMF - Pulse Electromagnetic Field reduces Parkinson’s symptoms.
I was diagnosed with PD in 2018 after 2 DaTscans. My main symptoms are rigidity, fatigue and...
Tapeworms and Parkinson’s
Parkinson’s and vagal nerve stimulation, promising human studies.
Smart watch for Parkinson’s 
iron supplements and Parkinson’s 
Leg pain in Parkinson’s 
